499 related articles for article (PubMed ID: 22084361)
1. Aspirin in the chemoprevention of colorectal neoplasia: an overview.
Chan AT; Arber N; Burn J; Chia WK; Elwood P; Hull MA; Logan RF; Rothwell PM; Schrör K; Baron JA
Cancer Prev Res (Phila); 2012 Feb; 5(2):164-78. PubMed ID: 22084361
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
3. Aspirin for the prevention of colorectal cancer.
Garcia-Albeniz X; Chan AT
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
5. Aspirin in the Prevention of Colorectal Neoplasia.
Drew DA; Chan AT
Annu Rev Med; 2021 Jan; 72():415-430. PubMed ID: 33035431
[TBL] [Abstract][Full Text] [Related]
6. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
7. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
9. [Aspirin for Chemoprevention of Colorectal Adenoma and Cancer].
Ishikawa H
Gan To Kagaku Ryoho; 2021 Dec; 48(12):1425-1428. PubMed ID: 34911904
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and the prevention of colorectal cancer.
Ferrández A; Piazuelo E; Castells A
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer chemoprevention: is aspirin still in the game?
Grancher A; Michel P; Di Fiore F; Sefrioui D
Cancer Biol Ther; 2022 Dec; 23(1):446-461. PubMed ID: 35905195
[TBL] [Abstract][Full Text] [Related]
12. Does aspirin reduce the incidence, recurrence, and mortality of colorectal cancer? A meta-analysis of randomized clinical trials.
Ma S; Han T; Sun C; Cheng C; Zhang H; Qu G; Bhan C; Yang H; Guo Z; Yan Y; Cao C; Ji Z; Zhou Q
Int J Colorectal Dis; 2021 Aug; 36(8):1653-1666. PubMed ID: 33594505
[TBL] [Abstract][Full Text] [Related]
13. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
[TBL] [Abstract][Full Text] [Related]
14. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.
Sehdev A; O'Neil BH
Curr Treat Options Oncol; 2015 Sep; 16(9):43. PubMed ID: 26187794
[TBL] [Abstract][Full Text] [Related]
15. Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
Kraus S; Sion D; Arber N
Curr Pharm Des; 2015; 21(35):5127-34. PubMed ID: 26369678
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis.
Dulai PS; Singh S; Marquez E; Khera R; Prokop LJ; Limburg PJ; Gupta S; Murad MH
BMJ; 2016 Dec; 355():i6188. PubMed ID: 27919915
[TBL] [Abstract][Full Text] [Related]
17. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
19. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
Dubé C; Rostom A; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
Ann Intern Med; 2007 Mar; 146(5):365-75. PubMed ID: 17339622
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]